bosentan anhydrous has been researched along with Malignant Hypertension in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cumming, AD; Firth, JD; Mullins, JJ; Veniant, MM; Whitworth, CE | 1 |
Li, JS; Schiffrin, EL; Schürch, W | 1 |
2 other study(ies) available for bosentan anhydrous and Malignant Hypertension
Article | Year |
---|---|
Endothelin in the kidney in malignant phase hypertension.
Topics: Animals; Autoradiography; Blood Pressure; Bosentan; Disease Susceptibility; Endothelins; Gene Expression; Hypertension; Hypertension, Malignant; Kidney; Male; Mice; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA; RNA, Messenger; Sulfonamides; Swine | 1995 |
Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
Topics: Animals; Arteries; Blood Pressure; Bosentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Hypertension, Malignant; Hypertrophy; Kidney; Organ Size; Rats; Rats, Inbred SHR; Renin; Sulfonamides | 1996 |